Wilhelmiina Niininen

Tampere, 33014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.

Journal: Cell death & disease

Published: February 27, 2022

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.

Journal: Cellular and molecular life sciences : CMLS

Published: February 13, 2022

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.

Journal: Cell death & disease

Published: February 25, 2020

Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.

Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.

Journal: Molecular cell

Published: January 20, 2020

Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.

Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.

Journal: Cells

Published: July 11, 2019

Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.

Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.

Journal: Oncogene

Published: July 24, 2018

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies.

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies.

Journal: Translational oncology

Published: May 08, 2018

Targeting Wnt signaling pseudokinases in hematological cancers.

Targeting Wnt signaling pseudokinases in hematological cancers.

Journal: European journal of haematology

Published: April 25, 2018

Interaction between ROR1 and MuSK activation complex in myogenic cells.

Interaction between ROR1 and MuSK activation complex in myogenic cells.

Journal: FEBS letters

Published: December 01, 2017

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.

Journal: Blood advances

Published: July 05, 2017

Targeting ROR1 identifies new treatment strategies in hematological cancers.

Targeting ROR1 identifies new treatment strategies in hematological cancers.

Journal: Biochemical Society transactions

Published: January 11, 2017

Myeloid cell expressed proprotein convertase FURIN attenuates inflammation.

Myeloid cell expressed proprotein convertase FURIN attenuates inflammation.

Journal: Oncotarget

Published: February 25, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026